5i Research Weekly Rockets and Duds This week's 5i Research Rockets and Duds Sarepta Therapeutics SR...
William Blair reissued their market perform rating on shares of Sarepta Therapeutics (NASDAQ:SRPT – ...
NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP a...
Exchange Traded Concepts LLC purchased a new position in shares of Sarepta Therapeutics, Inc. (NASDA...